RSS

ReNeuron Group

ReNeuron Group has announced that the FDA has approved the cryopreserved formulation of its human retinal progenitor cell (hRPC) therapeutic candidate, which enables it to be frozen for shipping and storage and thawed at the point of clinical use. more

19 Jun 2017 15:06 News